Photo of Anneke Van Der Walt

View Scopus Profile

Anneke Van Der Walt

Assoc Professor

 https://orcid.org/0000-0002-4278-7003
20052027
If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

A/Prof Anneke van der Walt is a Neurologist and a Principal Research Fellow at the Central Clinical School, Monash University.  She completed her undergraduate training in South Africa before relocating to Australia where she completed specialist training in Neurology and a PhD in Neuroscience under supervision of Professors Trevor Kilpatrick and Helmut Butzkueven at the University of Melbourne. Her research interests include treatment of MS tremor, cerebellar dysfunction in MS, and MS cognition. She has additional training in neuro-ophthalmology and works as a consultant at the Royal Victorian Eye and Ear Hospital. 

Van Der Walt Lab

External positions

Honorary Research Fellow, Bionics Institute

1 Feb 2015 → …

Consultant Neuroophthalmologist, The Royal Victorian Eye & Ear Hospital (RVEEH)

1 Feb 2008 → …

Research area keywords

  • Neuroscience
  • Multiple Sclerosis (MS)
  • Optic neuritis

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2015 2027

Active self-monitoring to prospectively detect treatment failure and define subclinical progression trajectories in multiple sclerosis: The ACTIVE-MS Program.

Van Der Walt, A., Butzkueven, H., Jokubaitis, V., Kolbe, S., Vogel, A. P., Stankovich, J., Butler, E., Macdonell, R. A. L. & Darby, D.

Trish Multiple Sclerosis Research Foundation

1/01/20 → 31/12/22

Project: Research

Monash-Roche Meaningful Data at Scale Collaboration for MS

Van Der Walt, A. & Butzkueven, H.

Hoffmann-La Roche

6/12/19 → 31/12/27

Project: Research

Pharmacogenomic prediction of treatment response in multiple sclerosis

Van Der Walt, A., Jokubaitis, V. & Butzkueven, H.

21/10/19 → 20/04/20

Project: Research

A prospective, multicenter, observational, post-authorization safety study to evaluate the long term safety profile of LEMTRADA (alemtuzumab) treatment in patients with relapsing forms of multiple sclerosis (Post Authorization Safety Study (PASS) Protocol).

Van Der Walt, A.

31/07/19 → 31/12/24

Project: Research

A Randomized, Controlled, Open-Label, Rater-Blinded, Phase 3b Study of the Efficacy, Safety, and Tolerability of 6-Week Extended Interval Dosing of Natalizumab (BG00002) in Subjects With Relapsing-Remitting Multiple Sclerosis Switching from Treatment with 4-Week Natalizumab Standard Interval Dosing (SID) in Relation to Continued SID Treatment.

Van Der Walt, A.

16/04/19 → 31/12/24

Project: Research

Research Output 2005 2020

1 Citation (Scopus)

Risk of secondary progressive multiple sclerosis: A longitudinal study

Fambiatos, A., Jokubaitis, V., Horakova, D., Kubala Havrdova, E., Trojano, M., Prat, A., Girard, M., Duquette, P., Lugaresi, A., Izquierdo, G., Grand’Maison, F., Grammond, P., Sola, P., Ferraro, D., Alroughani, R., Terzi, M., Hupperts, R., Boz, C., Lechner-Scott, J., Pucci, E. & 44 others, Bergamaschi, R., Van Pesch, V., Ozakbas, S., Granella, F., Turkoglu, R., Iuliano, G., Spitaleri, D., McCombe, P., Solaro, C., Slee, M., Ampapa, R., Soysal, A., Petersen, T., Sanchez-Menoyo, J. L., Verheul, F., Prevost, J., Sidhom, Y., Van Wijmeersch, B., Vucic, S., Cristiano, E., Saladino, M. L., Deri, N., Barnett, M., Olascoaga, J., Moore, F., Skibina, O., Gray, O., Fragoso, Y., Yamout, B., Shaw, C., Singhal, B., Shuey, N., Hodgkinson, S., Altintas, A., Al-Harbi, T., Csepany, T., Taylor, B., Hughes, J., Jun, J. K., van der Walt, A., Spelman, T., Butzkueven, H., Kalincik, T. & on behalf of the MSBase Study Group, Jan 2020, In : Multiple Sclerosis Journal. 26, 1, p. 79-90 12 p.

Research output: Contribution to journal › Article › Research › peer-review

Addressing the treatment gap in MS-associated tremor: A new door opens

van der Walt, A., 16 Oct 2019, (Accepted/In press) In : Multiple Sclerosis Journal. 1 p.

Research output: Contribution to journal › Comment / Debate › Other › peer-review

1 Citation (Scopus)

Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study

Lorscheider, J., Kuhle, J., Izquierdo, G., Lugaresi, A., Havrdova, E., Horakova, D., Hupperts, R., Duquette, P., Girard, M., Prat, A., Grand'Maison, F., Grammond, P., Sola, P., Ferraro, D., Trojano, M., Ramo-Tello, C., Lechner-Scott, J., Pucci, E., Solaro, C., Slee, M. & 7 others, Van Pesch, V., Sanchez Menoyo, J. L., van der Walt, A., Butzkueven, H., Kappos, L., Kalincik, T. & on behalf of the MSBase Study Group, 1 Feb 2019, In : European Journal of Neurology. 26, 2, p. 363-370 8 p.

Research output: Contribution to journal › Article › Research › peer-review

7 Citations (Scopus)

Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination

Tea, F., Lopez, J. A., Ramanathan, S., Merheb, V., Lee, F. X. Z., Zou, A., Pilli, D., Patrick, E., van der Walt, A., Monif, M., Tantsis, E. M., Yiu, E. M., Vucic, S., Henderson, A. P. D., Fok, A., Fraser, C. L., Lechner-Scott, J., Reddel, S. W., Broadley, S., Barnett, M. H. & 5 others, Brown, D. A., Lunemann, J. D., Dale, R. C., Brilot, F. & Australasian and New Zealand MOG Study Group, 3 Sep 2019, In : Acta neuropathologica communications. 7, 1, 22 p., 145.

Research output: Contribution to journal › Article › Research › peer-review

Open Access
File

Family planning, antenatal and post partum care in multiple sclerosis: a review and update

Van Der Walt, A., Nguyen, A. L. & Jokubaitis, V., Sep 2019, In : Medical Journal of Australia. 211, 5, p. 230-236 7 p.

Research output: Contribution to journal › Review Article › Research › peer-review